– USA, CA – Arine, an AI-driven SaaS platform company focused on medication intelligence, today announced the additions of Perry Wallack, Tom Cassels, and Dan Rosenthal to its Board of Directors, bringing deep leadership experience spanning the health and SaaS industries.
About Perry Wallack
Perry Wallack was co-founder and CFO of Cornerstone On-Demand from 1999 through 2016. Cornerstone was one of the first and largest SaaS companies in the world, going public in 2011. Cornerstone is an AI-powered talent experience platform, with over 125 million users across 138 countries with 7,000 customers. Cornerstone was taken private by Clearlake Capital Group in 2021 for an enterprise value of $5.2 billion. Wallack also serves or has served, on the boards of several SaaS companies, including Tebra, TigerConnect, Procore, and Pacvue.
About Tom Cassels
Tom Cassels brings over 20 years of experience as a strategic advisor to health plans, health systems, life sciences, and innovative technology companies. Cassels most recently launched and led Rock Health Advisory, a digital innovation strategy group working with 60+ Fortune 500 companies. Before Rock Health, he was CSO for the commercial arm of Leidos’ healthcare division, serving clients through enterprise SaaS tools, EHR modernizations, and direct care through Leidos’ 15,000 providers and 90+ clinics. Cassels began his career with the Advisory Board Company where he was a founding partner in the firm’s Strategy Consulting practice.
About Dan Rosenthal
Dan Rosenthal currently serves as an Advisory Partner for Andreessen Horowitz Bio + Health and a Senior Advisor for 111° West Capital. Rosenthal recently retired from a 20-year career at UnitedHealthcare, the fourth-largest US health insurer. While at UnitedHealthcare, Rosenthal was the CEO for Florida, California, and the West Region, spanning 13 states and 3 million members, for the company’s Employer & Individual Markets business. Rosenthal also served as President of UnitedHealthcare Networks and was responsible for all aspects of UnitedHealthcare’s Individual, Medicaid, Medicare, and Commercial Networks across the United States.
“Arine delivers a compelling approach to significantly decrease costs for care providers and payers, while enhancing care across their populations,” said Dan Rosenthal. “This is urgently needed at a time when health plans are challenged by increased costs and the need to shift quickly to value-based care models. Arine’s recent growth reflects the significant opportunity at hand and the demand for such innovative software platforms. I am excited to work with the team as they drive their commercial strategies forward.”
About Arine
Ariane is an AI-driven SaaS platform company focused on medication intelligence and led by some of the world’s top experts in pharmacotherapy, data analytics, health economics, engineering, and software development. Arine’s AI platform helps customers devise appropriate, just-in-time interventions to optimize medication management for their patients or members, expanding their outreach and care team efficiency. Health plans using Arine’s technology are shown to achieve significant ROI, improve patient clinical outcomes, and reduce the cost of care.
For more information: https://www.arine.io/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
